Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Babatunde O Oyajobi

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Arthritis Research & Therapy|July 20, 2007
Multiple myeloma/hypercalcemiaBabatunde O Oyajobi
Cancer|January 28, 2003
Receptor activator of NF-kappaB ligand, macrophage inflammatory protein-1alpha, and the proteasome: novel therapeutic targets in myelomaBabatunde O Oyajobi, Gregory R Mundy
Expert Opinion on Pharmacotherapy|December 2, 2005
Advances in the management of myeloma bone diseaseClaire M Shipman, Babatunde O Oyajobi, Gregory R Mundy
Cancer Research|February 5, 2009
Zerumbone abolishes RANKL-induced NF-kappaB activation, inhibits osteoclastogenesis, and suppresses human breast cancer-induced bone loss in athymic nude miceBokyung Sung, Akira Murakami, Babatunde O Oyajobi, et al.
Journal of Cellular Physiology|April 20, 2011
Functional redundancy of type II BMP receptor and type IIB activin receptor in BMP2-induced osteoblast differentiationHongbin Liu, Rongrong Zhang, Di Chen, et al.
The Journal of Biological Chemistry|May 10, 2003
E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiationMing Zhao, Mei Qiao, Babatunde O Oyajobi, et al.
Expert Opinion on Drug Delivery|February 1, 2011
Bone marrow-targeted liposomal carriersKeitaro Sou, Beth Goins, Babatunde O Oyajobi, et al.
The Journal of Biological Chemistry|January 1, 2004
Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivoMing Zhao, Mei Qiao, Stephen E Harris, et al.
Molecular and Cellular Biology|August 2, 2006
The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signalingMing Zhao, Mei Qiao, Stephen E Harris, et al.
Oncotarget|May 27, 2015
A dominant-negative F-box deleted mutant of E3 ubiquitin ligase, β-TrCP1/FWD1, markedly reduces myeloma cell growth and survival in miceRamaswamy Sharma, Paul J Williams, Anjana Gupta, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Arthritis Research & Therapy|July 20, 2007
Multiple myeloma/hypercalcemiaBabatunde O Oyajobi
Cancer|January 28, 2003
Receptor activator of NF-kappaB ligand, macrophage inflammatory protein-1alpha, and the proteasome: novel therapeutic targets in myelomaBabatunde O Oyajobi, Gregory R Mundy
Expert Opinion on Pharmacotherapy|December 2, 2005
Advances in the management of myeloma bone diseaseClaire M Shipman, Babatunde O Oyajobi, Gregory R Mundy
Cancer Research|February 5, 2009
Zerumbone abolishes RANKL-induced NF-kappaB activation, inhibits osteoclastogenesis, and suppresses human breast cancer-induced bone loss in athymic nude miceBokyung Sung, Akira Murakami, Babatunde O Oyajobi, et al.
Journal of Cellular Physiology|April 20, 2011
Functional redundancy of type II BMP receptor and type IIB activin receptor in BMP2-induced osteoblast differentiationHongbin Liu, Rongrong Zhang, Di Chen, et al.
The Journal of Biological Chemistry|May 10, 2003
E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiationMing Zhao, Mei Qiao, Babatunde O Oyajobi, et al.
Expert Opinion on Drug Delivery|February 1, 2011
Bone marrow-targeted liposomal carriersKeitaro Sou, Beth Goins, Babatunde O Oyajobi, et al.
The Journal of Biological Chemistry|January 1, 2004
Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivoMing Zhao, Mei Qiao, Stephen E Harris, et al.
Molecular and Cellular Biology|August 2, 2006
The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signalingMing Zhao, Mei Qiao, Stephen E Harris, et al.
Oncotarget|May 27, 2015
A dominant-negative F-box deleted mutant of E3 ubiquitin ligase, β-TrCP1/FWD1, markedly reduces myeloma cell growth and survival in miceRamaswamy Sharma, Paul J Williams, Anjana Gupta, et al.
Pageof 3